HO-1 overexpression in several cancer types was shown to reduce tumor size, to increase sensitivity of the cells for apoptosis inducing drugs, to reduce tumor burden in animal models, and to result in longer survival time of patients [72,73]. This evidence concerns the gene HMOX1 and neoplasm.